Engineered Listeria and methods of use thereof
US8580939B2 · kind B2 · utility
2Cited by
13References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2011 |
| Grant date | Nov 12, 2013 |
| Priority date | — |
| Expiry date | May 2, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a bacterium containing a polynucleotide comprising a nucleic acid encoding a heterologous antigen, as well as fusion protein partners. Also provided are vectors for mediating site-specific recombination and vectors comprising removable antibiotic resistance genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.